Children cannot continue to wait. “Treatments, vaccines, and other preventive tools should be evaluated for use in children from the outset of research efforts and made available to them without delay,” says Dr Manangama, epidemiologist and deputy director of operations at MSF.
Children are being left behind in the research of innovative medical tools for the current Ebola disease outbreak in DRC. Children are also disproportionately impacted by the outbreak, with the youngest facing the highest risk of death.